ATE49749T1 - Aminosaeurederivate mit antitumoraktivitaet sowie diese derivate enthaltende zusammensetzungen. - Google Patents
Aminosaeurederivate mit antitumoraktivitaet sowie diese derivate enthaltende zusammensetzungen.Info
- Publication number
- ATE49749T1 ATE49749T1 AT85305052T AT85305052T ATE49749T1 AT E49749 T1 ATE49749 T1 AT E49749T1 AT 85305052 T AT85305052 T AT 85305052T AT 85305052 T AT85305052 T AT 85305052T AT E49749 T1 ATE49749 T1 AT E49749T1
- Authority
- AT
- Austria
- Prior art keywords
- derivatives
- amino acid
- antitumoric
- activity
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyridine Compounds (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Preventing Corrosion Or Incrustation Of Metals (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59145731A JPH0662529B2 (ja) | 1984-07-13 | 1984-07-13 | アミノ酸誘導体 |
EP85305052A EP0173441B1 (de) | 1984-07-13 | 1985-07-15 | Aminosäurederivate mit Antitumoraktivität sowie diese Derivate enthaltende Zusammensetzungen |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE49749T1 true ATE49749T1 (de) | 1990-02-15 |
Family
ID=15391835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT85305052T ATE49749T1 (de) | 1984-07-13 | 1985-07-15 | Aminosaeurederivate mit antitumoraktivitaet sowie diese derivate enthaltende zusammensetzungen. |
Country Status (7)
Country | Link |
---|---|
US (1) | US4904680A (de) |
EP (1) | EP0173441B1 (de) |
JP (1) | JPH0662529B2 (de) |
AT (1) | ATE49749T1 (de) |
CA (1) | CA1283917C (de) |
DE (1) | DE3575554D1 (de) |
ES (3) | ES8703830A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01250370A (ja) * | 1987-12-23 | 1989-10-05 | Zeria Pharmaceut Co Ltd | 新規アミノ酸イミド誘導体、製法ならびに用途 |
FR2646847B1 (fr) * | 1989-05-12 | 1991-07-12 | Rhone Poulenc Sante | N-phenyl amides, leurs procedes de preparation et les medicaments les contenant |
JPH0524090U (ja) * | 1991-09-20 | 1993-03-30 | 仲秋 張 | ジグソーパズル |
HU211995B (en) * | 1992-06-30 | 1996-01-29 | Gyogyszerkutato Intezet | Process to prepare novel benzoyl amino acid derivs. and pharmaceutical compns. contg.them |
US5854250A (en) * | 1995-10-11 | 1998-12-29 | Gyogyszerkutato Intezet Kft | N-benzoylamino acid derivatives, pharmaceutical compositions containing them and process of preparing same |
EP1034163A1 (de) * | 1997-05-07 | 2000-09-13 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin | Cysteinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
EP1045836B1 (de) * | 1997-12-18 | 2008-03-05 | Boehringer Ingelheim Pharmaceuticals Inc. | Pyridone als hemmer der sh2-domäne der src-familie |
US7427496B2 (en) * | 1999-06-25 | 2008-09-23 | The Regents Of The University Of Colorado | Anti-cancer compounds |
US7119085B2 (en) | 2000-03-23 | 2006-10-10 | Elan Pharmaceuticals, Inc. | Methods to treat alzheimer's disease |
JP2004502665A (ja) | 2000-06-30 | 2004-01-29 | イーラン ファーマスーティカルズ、インコーポレイテッド | アルツハイマー病を治療する化合物 |
ZA200406763B (en) * | 2002-03-28 | 2005-09-30 | Applied Research Systems | Thiazolidine carboxamide derivatives as modulatorsof the prostaglandin F receptor. |
DE102005028492A1 (de) * | 2005-06-20 | 2006-12-28 | Basf Ag | Verfahren zur Herstellung von optisch aktiven Aminoalkylphenolen |
AR112804A1 (es) * | 2017-09-13 | 2019-12-11 | Amgen Inc | Compuestos de bisamida que activan el sarcómero y sus usos |
CN117945945A (zh) * | 2022-10-28 | 2024-04-30 | 浙江友宁生物医药科技有限公司 | 一种gpr139受体激动剂、其制备方法及其应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE213641C (de) * | ||||
DE1236519B (de) * | 1959-09-19 | 1967-03-16 | Nippon Shinyaku Co Ltd | Verfahren zum Herstellen eines analgetisch wirksamen Salicylsaeure-Derivates |
DE1793613A1 (de) * | 1966-05-13 | 1971-09-02 | Francia Farma | gamma-Orthohydroxybenzamidbutyramid |
CH513123A (de) * | 1967-09-25 | 1971-09-30 | Bayer Ag | Verfahren zur Herstellung von N-Acyl-a-aminosäureamiden bzw. -peptiden |
IE33790B1 (en) * | 1968-06-04 | 1974-10-30 | Beecham Group Ltd | Derivatives of n-acylaminoacid amides |
DE2139641A1 (de) * | 1971-08-07 | 1973-02-15 | Bayer Ag | 2-(p-chlorbenzoylamino)-carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
AU518147B2 (en) * | 1976-12-03 | 1981-09-17 | E.R. Squibb & Sons, Inc. | Derivatives of thiazolidine, thiazine and morpholine carboxylic acids |
DE3276110D1 (en) * | 1981-03-04 | 1987-05-27 | Ici Plc | Amide derivatives, processes for preparing them, their use as fungicides and pesticidal compositions containing them |
-
1984
- 1984-07-13 JP JP59145731A patent/JPH0662529B2/ja not_active Expired - Fee Related
-
1985
- 1985-07-12 ES ES545170A patent/ES8703830A1/es not_active Expired
- 1985-07-15 CA CA000486792A patent/CA1283917C/en not_active Expired - Fee Related
- 1985-07-15 EP EP85305052A patent/EP0173441B1/de not_active Expired - Lifetime
- 1985-07-15 AT AT85305052T patent/ATE49749T1/de not_active IP Right Cessation
- 1985-07-15 DE DE8585305052T patent/DE3575554D1/de not_active Expired - Fee Related
-
1986
- 1986-11-13 ES ES557196A patent/ES8801185A1/es not_active Expired
- 1986-11-13 ES ES557197A patent/ES8801186A1/es not_active Expired
-
1988
- 1988-01-22 US US07/146,955 patent/US4904680A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE3575554D1 (de) | 1990-03-01 |
ES545170A0 (es) | 1987-03-01 |
ES8703830A1 (es) | 1987-03-01 |
JPS6124550A (ja) | 1986-02-03 |
ES8801185A1 (es) | 1988-01-01 |
ES557196A0 (es) | 1988-01-01 |
EP0173441B1 (de) | 1990-01-24 |
ES557197A0 (es) | 1988-01-01 |
US4904680A (en) | 1990-02-27 |
CA1283917C (en) | 1991-05-07 |
EP0173441A1 (de) | 1986-03-05 |
JPH0662529B2 (ja) | 1994-08-17 |
ES8801186A1 (es) | 1988-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE60761T1 (de) | Chinazolinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
ES473451A1 (es) | Un procedimiento para la preparacion de derivados de imida- zol. | |
ATE49749T1 (de) | Aminosaeurederivate mit antitumoraktivitaet sowie diese derivate enthaltende zusammensetzungen. | |
DK602589D0 (da) | Quinazolinonderivater | |
ES480109A1 (es) | Procedimkiento para la preparacion de derivados de imidazo- lidina. | |
ES8605511A1 (es) | Un procedimiento para la preparacion de derivados de tiazol,2, 4, disustituidos. | |
BE905109A (fr) | Derives de distamycine et leur procede de fabrication. | |
ATE38991T1 (de) | In 2-stellung substituierte 1,3propyledendephosphonat-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten. | |
FR2684103B1 (fr) | Nouveaux composes a structure guanidique et composition pharmaceutique les contenant. | |
DE69526917D1 (de) | Anthracyclinon-derivate und ihre verwendung in amyloidose | |
GR3005227T3 (de) | ||
IT1224405B (it) | Composti attivi sul sistema cardiovascolare | |
ES8704153A1 (es) | Un procedimiento para preparar derivados de pirimidina | |
ES468170A1 (es) | Un procedimiento para la preparacion de un nuevo derivado demorfina | |
IS4725A (is) | Afleiður amidíns og ísóþíóþvagefnis er hindra nítrítoxíðsyntasa | |
IT1216104B (it) | Peptidi ad attivita' farmaceutica. | |
DE3668888D1 (de) | Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung. | |
ES2128313T3 (es) | Naftalimidas n-substituidas, su obtencion y empleo. | |
NO870423L (no) | 5-substituerte oktahydroindolizin-analgetiske forbindelser og 7-keto mellomprodukter. | |
DK7286D0 (da) | Octahydroindoliziner | |
ATE28647T1 (de) | Chinazolinonderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln. | |
ATE40118T1 (de) | Benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel. | |
ES8505665A1 (es) | Procedimiento para preparar derivados acilaminofenolicos | |
ES556048A0 (es) | Un procedimiento para la preparacion de un derivado de tiazolidina. | |
IT1216103B (it) | Peptidi ad attivita' farmaceutica. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |